Newtyn Management, LLC Sensei Biotherapeutics, Inc. Transaction History
Newtyn Management, LLC
- $464 Million
- Q1 2024
A detailed history of Newtyn Management, LLC transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Newtyn Management, LLC holds 930,230 shares of SNSE stock, worth $679,067. This represents 0.21% of its overall portfolio holdings.
Number of Shares
930,230
Previous 1,572,023
40.83%
Holding current value
$679,067
Previous $1.08 Million
9.96%
% of portfolio
0.21%
Previous 0.23%
Shares
7 transactions
Others Institutions Holding SNSE
# of Institutions
27Shares Held
2.32MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA574KShares$418,9060.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny211KShares$154,0300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA136KShares$99,5120.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX113KShares$82,4170.0% of portfolio
-
Bank Of America Corp Charlotte, NC90.8KShares$66,2560.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $22.4M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...